⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29754822 | 1.00 | — | — | |
| SCHEMBL24676513 | 0.82 | — | — | |
| SCHEMBL29754816 | 0.82 | — | — | |
| SCHEMBL29755010 | 0.81 | — | — | |
| SCHEMBL24676742 | 0.81 | — | — | |
| SCHEMBL24676721 | 0.79 | CDK2 (0.47) | — | |
| SCHEMBL29754866 | 0.77 | — | — | |
| SCHEMBL24676975 | 0.77 | — | — | |
| SCHEMBL24676727 | 0.73 | KMT2A (0.30) | — | |
| SCHEMBL24676973 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022155941-A1 | CDK2 INHIBITORS | QILU REGOR THERAPEUTICS INC. (CN) | 2022-07-28 | — | — | WO | disclosed |